Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 9499 matches for

Twelve outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition. The shortlist includes our DPhil student Magda Mareckova (pictured).

Good luck to our DPhil student Magda Mareckova. Her article: “One in ten women suffers from endometriosis - can studying the endometrium cell by cell help us diagnose it?” is shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition.

AI Identifies Reproducible Clinical Subtypes of Alzheimer’s and Parkinson’s Disease

Published in Nature Aging today, five distinct subtypes of Alzheimer’s and Parkinson’s disease have been identified by using Artificial Intelligence to analyse healthcare data from over 100,000 patients.

Generation Study - tests your baby for 200+ conditions

The Generation Study tests your baby for 200+ conditions. The test is free, safe, and takes place just after birth.

Early-Phase Study Demonstrates Safety and Immune Response of Therapeutic HPV Vaccine

An early-phase clinical trial has reported results evaluating a new therapeutic vaccine designed to help the body clear high-risk human papillomavirus (HPV) infection in women with low-grade cervical lesions.

MitOX 2026 - Thursday, 9 April 2026

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2026 on Thursday, 9 April 2026 in Tingewick Hall, John Radcliffe Hospital, Oxford.

COVID-19 Vaccination During Pregnancy Offers New Insight into Preeclampsia Prevention

A new multinational study from the INTERCOVID Consortium, led by researchers from the University of Oxford, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication. The findings offer unprecedented insight into preeclampsia prevention, independent of the direct effects of COVID-19 infection.

New AI model Could Improve Prediction of Medium-Term Mortality in Heart Failure Patients

Researchers from the University of Oxford and international collaborators have developed a new artificial intelligence model that can more accurately predict the medium-term risk of death for people with heart failure using routine electronic health records.

AI ‘digital assistant’ could transform fetal ultrasound training and support

Researchers from the University of Oxford, including clinicians and scientists from the Nuffield Department of Women’s & Reproductive Health (WRH), have developed a new artificial intelligence (AI) system to assist clinicians during fetal ultrasound scans in real time.

New Study reveals how egg cells mature in anolis lizards

Researchers from NDWRH and the MD Anderson Cancer Center shed light into the egg cell maturation in lizard ovaries by providing a detailed characterisation of the individual stages a reptile egg cell must pass through before it ovulates.

The Changing Face of Heart Disease: Why It’s Time to Rethink Prevention

For decades, heart disease prevention has been one of the biggest public health success stories. Thanks to research and better awareness about risks like high blood pressure, smoking, and cholesterol, rates of heart attacks and strokes have fallen dramatically since the 1960s. But in recent years, this progress has slowed, and in some countries, even reversed. Despite medical advances, the number of people being diagnosed with heart and circulatory diseases has stayed roughly the same since the mid-2000s. Rising rates of obesity, diabetes, and chronic kidney disease are thought to play a big role in this worrying trend.

National Perinatal Epidemiology Unit officially joins the Nuffield Department of Women’s & Reproductive Health

The University of Oxford is pleased to announce that, as of Monday 2 February, the National Perinatal Epidemiology Unit (NPEU) has officially joined the Nuffield Department of Women’s & Reproductive Health (NDWRH). This marks a significant milestone in a partnership first announced in 2025 and represents a major strategic step in strengthening Oxford’s leadership in women’s, maternal and reproductive health research and education.

Oxford Spinout Launches AI-based Ultrasound Technology to Improve Early Detection of Pregnancy Complications

A new University of Oxford spinout, Oxailis Ltd, has launched an AI-based ultrasound technology that enables healthcare professionals to measure perfusion (how effectively oxygen-rich blood is delivered to tissue), using existing standard ultrasound hardware and without the need for contrast agents.

Upcoming Virtual Open Events for Prospective Masters Students

With the deadline for 2026 entry fast approaching, the Nuffield Department of Women’s & Reproductive Health (NDWRH) is inviting prospective students to attend three upcoming virtual open events. These sessions will provide an opportunity to explore two new Oxford University postgraduate courses launching in 2026: the MSc in Reproductive Genetics and the MSc in Global Women’s Health, alongside the department’s well-established MSc in Clinical Embryology.

New WHO Meta-Analysis Suggests Better Clinical Markers Could Improve Early Detection of Postpartum Haemorrhage

A major international research collaboration has published new evidence in The Lancet that could transform how postpartum haemorrhage (PPH) is diagnosed and treated around the world. The study - an individual participant data (IPD) meta-analysis involving more than 312,000 women from diverse clinical settings - was led by scientists including Dr Adam Devall and Prof Arri Coomarasamy.

Unequal access to early pregnancy scans delays detection of serious conditions

Early screening resulted in earlier detection for 40% of anomalies, including heart and limb issues. Researchers from the University of Oxford, together with colleagues from the NHS and other partners, have published the first population-level study linking first-trimester ultrasound practice with early detection rates for serious congenital anomalies.

Early Diagnosis Saves Lives: New Study Highlights Critical Window for Postpartum Haemorrhage Care

A new international study co-led by Professor Arri Coomarasamy of the University of Birmingham and the Nuffield Department of Women’s and Reproductive Health, University of Oxford, has shown that diagnosing postpartum haemorrhage (PPH) within the first 90 minutes after childbirth can be crucial in preventing maternal deaths.

From Oxford to Empowerment: Why Fertility Awareness Matters

We’re delighted to share an inspiring piece by Maryam Rahbar, a former MSc in Clinical Embryology and DPhil student in Women’s & Reproductive Health at Oxford. Drawing on her academic journey and passion for translating science into empowerment, Maryam explores the science and significance of fertility awareness and preservation. Her reflections remind us that informed choice, grounded in knowledge, not fear, is one of the most powerful forms of reproductive autonomy.

Oxford researchers awarded funding to pioneer ovarian cancer vaccine development

Ovarian cancer remains a devastating global health challenge: each year, over 300,000 women are diagnosed, and nearly 200,000 lives are lost, largely because the disease is detected at a late stage. Women carrying inherited genetic changes face a significantly elevated lifetime risk, over 40%, and current preventive strategies often require invasive surgery that compromises fertility. These limitations underscore an urgent need for non-surgical preventive options, and vaccines could offer a groundbreaking solution.

From pain to policy: global reviews call for urgent action on endometriosis in most world regions

First global mapping shows half the world’s countries lack policies or guidelines for endometriosis, affecting >200 million women and girls.

Places available for IF Oxford Festival panel discussion

Why is women’s pain often dismissed or misunderstood? Attend our panel discussion on the realities of pain in women, from endometriosis and period pain to IUD insertion and pain during consensual sex.

Celebrating Excellence: MSc in Clinical Embryology 2024–25 Prize Winners Announced

We are delighted to announce the prize winners from Cohort 17 (2024–25) of the MSc in Clinical Embryology. These awards recognise outstanding achievement, dedication, and excellence across research, academic performance, and professional development.

Load More

Latest news

AI Identifies Reproducible Clinical Subtypes of Alzheimer’s and Parkinson’s Disease

Published in Nature Aging today, five distinct subtypes of Alzheimer’s and Parkinson’s disease have been identified by using Artificial Intelligence to analyse healthcare data from over 100,000 patients.

Generation Study - tests your baby for 200+ conditions

The Generation Study tests your baby for 200+ conditions. The test is free, safe, and takes place just after birth.

Early-Phase Study Demonstrates Safety and Immune Response of Therapeutic HPV Vaccine

An early-phase clinical trial has reported results evaluating a new therapeutic vaccine designed to help the body clear high-risk human papillomavirus (HPV) infection in women with low-grade cervical lesions.

MitOX 2026 - Thursday, 9 April 2026

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2026 on Thursday, 9 April 2026 in Tingewick Hall, John Radcliffe Hospital, Oxford.

More news

Related new stories

Upcoming OxTalks

Our Research Groups